Table 2.
Animal studies investigating the role of HMGB1 in TBI.
| Study | Animal | Injury | Group Design (n) |
Treatment | Sampling Method |
Time Points Measured |
Motor function Test |
|---|---|---|---|---|---|---|---|
| Gao (2012) | Rat | Modified Feeney’s weight drop | 5 sham vs. 50 TBI | None. | IHC, WB | 0.5h, 1h, 2h, 4h, 6h, 12h, 1d, 3d, 6d | None |
| Laird (2014) | Mouse | Controlled cortical impact | TBI vs. sham; wild-type vs. (6–10 / experiment) | TLR4, NR 2A, NR2B antagonists | WB, ELISA, IHC, qRT-PCR | 1h, 3h, 6h, 12h, 18h, 24h | None |
| Okuma (2012) | Mouse & Rat | Fluid percussion injury | 5 TBI + IgG control vs. 5 TBI + Gly vs. 5 sham | Anti-HMGB1 mAb | ELISA, WB, RT-PCR | 3h, 6h, 24h | Blinded accelerated rotarod test; forelimb use |
| Okuma (2014) | Mouse & Rat | Fluid percussion injury | 5 TBI+control vs. 5 TBI + Anti-HMGB1 mAb vs. 5 sham | Gly | IHC, WB, RT-PCR | 5m, 3h, 6h, 24h | Blinded rotarod test; forelimb movement test |
| Su (2011) | Rat | Modified Feeney’s weight drop | 30 sham vs. 30 TBI vs. 30 TBI+EP | Ethyl pyruvate | WB, ELISA, RT-PCR, EMSA | 24h | Beam-walking balance test |
| Xiangjin (2014) | Rat | Modified Feeney’s weight drop | 36 sham vs. 36 TBI vs. 36 TBI+Gly | Gly | IHC, WB, ELISA, EMSA, RT-PCR | 24h | Beam-walking balance test |
Abbreviations: enzyme-linked immunosorbent assay, ELISA; electrophoretic mobility shift assay, EMSA; Glycyrrhizin, Gly; immunoglobulin G, IgG; monoclonal antibody, mAb; N-methyl-D-aspartate receptor 2A subunit, NR2A; N-methyl-D-aspartate receptor 2B subunit, NR2B; polymerase chain reaction, PCR; Toll-like receptor, TLR; traumatic brain injury, TBI; Western blot, WB